TLSA (Tiziana Life Sciences Ltd. Common Shares) Stock Analysis - Analyst Ratings

Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of May 19, 2026, TLSA trades at $1.38 with a market cap of $171.80M and a P/E ratio of 0.00. TLSA moved +2.96% today. Year to date, TLSA is -13.75%; over the trailing twelve months it is -6.76%. Its 52-week range spans $0.63 to $2.60. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate TLSA?

The average price target is $0.00.

TLSA Key Metrics

Key financial metrics for TLSA
MetricValue
Price$1.38
Market Cap$171.80M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$2.60
52-Week Low$0.63
Volume243.75K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

TLSA Analyst Consensus

TLSA analyst coverage data. Average price target: $0.00.

Latest TLSA News

Common questions about TLSA

What do analysts rate TLSA?
The average price target is $0.00.
Does Rallies show TLSA price targets?
Yes. Rallies tracks TLSA analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is TLSA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TLSA. It does not provide personalized investment advice.
TLSA

TLSA